In patients with atherosclerotic cardiovascular disease, study authors from Stanford University found that those who received high-intensity statins had the biggest reduction in mortality risk. In ...

Among more than 500,000 patients with atherosclerotic cardiovascular disease, researchers found an inverse association between intensity of statin therapy and mortality, with patients who received ...

High-intensity statin therapy is associated with a “small but significant” reduction in the risk of all-cause mortality when compared with moderate-intensity statin therapy in individuals with ...

PALO ALTO, CA — Observational data from more than half a million veterans with established atherosclerotic CVD (ASCVD) suggest that high-intensity statins reduce all-cause mortality, even in older ...

Two new studies published this week highlight the successes, as well as the disappointments, in the battle to get patients to take a high-intensity statin for secondary prevention. In the “good news” ...

Compared with high-intensity statin therapy, moderate intensity statin therapy plus ezetimibe was equally effective in preventing CV events among patients undergoing PCI. Moderate-intensity statin ...

Researchers from the University of Alabama at Birmingham Division of Cardiovascular Disease and School of Public Health have published new research that suggests geographic region is the strongest ...

Please provide your email address to receive an email when new articles are posted on . In a retrospective analysis published in JAMA Cardiology, high-intensity statin use was associated with a ...

Please provide your email address to receive an email when new articles are posted on . In a study of about 65,000 U.S. veterans with chronic kidney disease, investigators found no significant link ...

Credit: Shutterstock. Small increases in the risk for statin-associated muscle symptoms were observed for patients on high-intensity therapy. While statins are known to cause musculoskeletal symptoms, ...

The combination of ezetimibe and a moderate-intensity statin after coronary stenting may be safer and more clinically effective than monotherapy with a high-intensity statin, suggests a "real-world" ...

Statin therapy demonstrated a dose-dependent increase in the risk for new-onset diabetes, especially among individuals already at high risk for diabetes. Higher doses of statin therapy moderately ...